Literature DB >> 10025836

Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.

G L Chan1, J E Holden, A J Stoessl, A Samii, D J Doudet, T Dobko, K S Morrison, M Adam, M Schulzer, D B Calne, T J Ruth.   

Abstract

UNLABELLED: The reproducibility of (+/-)-alpha-[11C] dihydrotetrabenazine (DTBZ) measures in PET was studied in 10 healthy human subjects, aged 22-76 y.
METHODS: The scan-to-scan variation of several measures used in PET data analysis was determined, including the radioactivity ratio (target-to-reference), plasma-input Logan total distribution volume (DV), plasma-input Logan Bmax/Kd and tissue-input Logan Bmax/Kd values.
RESULTS: The radioactivity ratios, plasma-input Bmax/Kd and tissue-input Bmax/Kd all have higher reliability than plasma-input total DV values. In addition, measures using the occipital cortex as the reference region have higher reliability than the same measures using the cerebellum as the reference region.
CONCLUSION: Our results show that DTBZ is a reliable PET tracer that provides reproducible in vivo measurement of striatal vesicular monoamine transporter density. In the selection of reference regions for DTBZ PET data analysis, caution must be exercised in circumstances when DTBZ binding in the occipital cortex or the cerebellum may be altered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025836

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Beta-cell imaging: call for evidence-based and scientific approach.

Authors:  Björn A Blomberg; Ion Codreanu; Gang Cheng; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

2.  Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.

Authors:  Leigh Christopher; Connie Marras; Sarah Duff-Canning; Yuko Koshimori; Robert Chen; Isabelle Boileau; Barbara Segura; Oury Monchi; Anthony E Lang; Pablo Rusjan; Sylvain Houle; Antonio P Strafella
Journal:  Brain       Date:  2013-12-12       Impact factor: 13.501

3.  In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

Authors:  Rajesh Narendran; Brian J Lopresti; Diana Martinez; Neale Scott Mason; Michael Himes; Maureen A May; Dennis C Daley; Julie C Price; Chester A Mathis; W Gordon Frankle
Journal:  Am J Psychiatry       Date:  2011-10-31       Impact factor: 18.112

4.  Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.

Authors:  Leigh Christopher; Sarah Duff-Canning; Yuko Koshimori; Barbara Segura; Isabelle Boileau; Robert Chen; Anthony E Lang; Sylvain Houle; Pablo Rusjan; Antonio P Strafella
Journal:  Ann Neurol       Date:  2014-12-30       Impact factor: 10.422

5.  Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies.

Authors:  Junchao Tong; Isabelle Boileau; Yoshiaki Furukawa; Li-Jan Chang; Alan A Wilson; Sylvain Houle; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

6.  Comparison of Invasive and Non-invasive Estimation of [11C]PBR28 Binding in Non-human Primates.

Authors:  Lucero Aceves-Serrano; Vesna Sossi; Doris J Doudet
Journal:  Mol Imaging Biol       Date:  2021-10-07       Impact factor: 3.488

7.  Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.

Authors:  Isabelle Boileau; Tina McCluskey; Junchao Tong; Yoshiaki Furukawa; Sylvain Houle; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2015-08-31       Impact factor: 7.853

8.  [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies.

Authors:  Brad A Racette; Laura Good; Jo Ann Antenor; Lori McGee-Minnich; Stephen M Moerlein; Tom O Videen; Joel S Perlmutter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-04-05       Impact factor: 3.568

9.  Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation.

Authors:  Rajesh Narendran; William G Frankle; Neale S Mason; Matthew F Muldoon; Bita Moghaddam
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

10.  Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.

Authors:  Kun-Ju Lin; Yi-Hsin Weng; Chia-Ju Hsieh; Wey-Yil Lin; Shiaw-Pyng Wey; Mei-Ping Kung; Tzu-Chen Yen; Chin-Song Lu; Ing-Tsung Hsiao
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.